Autologous stem cell transplantation for primary refractory or relapsing Hodgkin's disease: Comparison between CD34+ immunoselected and unselected stem cells graft

Gene Therapy and Molecular Biology

Volumn 11, Issue 1, 2007, Pages 21-26

  Sorà, Federica ^a   Di Febo, Anna Laura ^a   Piccirillo, Nicola ^a   Laurenti, Luca ^a   Chiusolo, Patrizia ^a   De Matteis, Silvia ^a   Leone, Giuseppe ^a   Sica, Simona ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autologous stem cell transplantation; CD34+; Cell immnuoselection; Hodgkin's disease

Indexed keywords

EID: 34848814393     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bierman PJ, Lynch JC, Bociek RG, Whalen VL, Kessinger A, Vose JM, Armitage JO (2002) The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol 13, 1370-7.
2. Blystad AK, Holte H, Kvaloy S Smeland E, Delabie J, Kvalheim G (2001a) High dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells. Bone Marrow Transplant 3, 295-305.
3. Blystad AK, Torlakovic E, Holte H, Blystad AK, Torlakovic E, Holte H, Kvaloy S, Lenschow E, Kvalheim G (2001b) CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD. Cytotherapy 28, 849-57.
4. Centers for Disease Control and Prevention (CDC) (2002) MMWR Morb Mortal Wkly Rep. 50, 27-28.
5. Constans M, Sureda A, Terol MJ Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, Leon A, Lopez A, Albo C, Diaz-Mediavilla J, Fernandez-Abellan P, Garcia-Ruiz JC, Hernandez-Navarro F, Mataix R, Petit J, Pascual MJ, Rifon J, Garcia-Conde J, Fernandez-Ranada JM, Mateos MV, Sierra J, Conde E; GEL/TAMO Cooperative Group (2003) Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome. Ann Oncol 14, 745-51.
6. Horning SJ, Chao NJ, Negrin RS Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW, Wong RM, Brown BW, Blume KG (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Blood 89, 801-13.
7. Kanzler H, Hansmann ML, Kapp U Wolf J, Diehl V, Rajewsky K, Kuppers R (1996) Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed Sternberg cells of a Hodgkin's lymphoma patient. Blood 87, 3429-36.
8. La Barbera EO, Chiusolo P, Laurenti L Menichella G, Di Febo AL, Piccirillo N, Sora E, Marra R, Teofili L, Leone G, Sica S (2000) MiCMA: an alternative treatment for refractory or recurrent Hodgkin's disease. Ann Oncol 11, 867-71.
9. Lakota J, Ballova V, Drgona L, Durkovic P, Vranovsky A (2002) Use of selected CD34+ cells in the treatment of relapsed/progressive HD: experiences from a single center. Cytotherapy 4, 177-80.
10. Majolino, I, Pearce R, Taghipour G, Goldstone AH (1997) Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 15, 509-17.
11. Paltiel O, Rubinstein C, Or R Nagler A, Gordon L, Deutsch L, Polliack A, Naparstek E (2003) Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma. Bone Marrow Transplant 31, 565-9.
12. Salutari P, Sica S, Laurenti L, Leone F, Chiusolo P, Piccirillo N, Micciulli G, Leone G (1998) Incidence of sepsis after peripheral blood progenitor cells transplantation: analysis of 86 consecutive hemato oncological patients. Leuk Lymphoma 30, 193-7.
13. Schmitz N, Pfistner B, Sextro M Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Muller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V; German Hodgkin's Lymphoma Study Group; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359, 2065-71.
14. Shamash J, Lee SM, Radford JA, Rohatiner AZ, Chang J, Morgenstern GR, Scarffe JH, Deakin DP, Lister TA (2000) Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study. Ann Oncol 11, 715-9.
15. Sharp JG, Chan WC (1999) Detection and relevance of minimal disease in lymphomas. Cancer Methastasis Revs 18, 127-42.
16. Sharp JG, Kessinger A, Piruccello SJ (1991) Frequency of detection of suspected lumphoma cell in peripheral blood stem cell collection. In: Dicke KA, Armitage JO, Dicke Evinger MJ (eds) Autologous Bone Marrow Transplantation University of Nebraska Medical Centre: Ohama, 801-810.
17. Sweetenham JW, Carella AM, Taghipour G Cunningham D, Marcus R, Della Volpe A, Linch DC, Schmitz N, Goldstone AH (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. J Clin Oncol 17, 3101-9.
18. Wolf J, Kapp U, Bohlen H Kornacker M, Schoch C, Stahl B, Mucke S, von Kalle C, Fonatsch C, Schaefer HE, Hansmann ML, Diehl V (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 87, 3418-28.